Shionogi & Co., Ltd. (TYO:4507)
2,554.00
+10.50 (0.41%)
Jul 25, 2025, 3:30 PM JST
Shionogi & Employees
Shionogi & had 4,955 employees as of March 31, 2025. The number of employees decreased by 4 or -0.08% compared to the previous year.
Employees
4,955
Change (1Y)
-4
Growth (1Y)
-0.08%
Revenue / Employee
88.45M JPY
Profits / Employee
34.40M JPY
Market Cap
2,172.66B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 4,955 | -4 | -0.08% |
Mar 31, 2024 | 4,959 | -721 | -12.69% |
Mar 31, 2023 | 5,680 | -13 | -0.23% |
Mar 31, 2022 | 5,693 | 208 | 3.79% |
Mar 31, 2021 | 5,485 | 263 | 5.04% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Chugai Pharmaceutical | 5,026 |
Takeda Pharmaceutical Company | 47,455 |
Daiichi Sankyo Company | 19,765 |
HOYA Corporation | 37,909 |
Otsuka Holdings | 35,338 |
Astellas Pharma | 13,643 |
Olympus | 29,297 |
Sysmex | 10,533 |
Shionogi & News
- 2 months ago - Shionogi & Co. GAAP EPS of ¥200.29, revenue of ¥438.27B - Seeking Alpha
- 2 months ago - Shionogi to buy Japan Tobacco’s Torii Pharma in a deal worth over $1B - Seeking Alpha
- 6 months ago - Shionogi and Jordan's Guardian Angels Announce First-Ever Human Drug Study for Jordan's Syndrome, an Ultra-Rare Genetic Neurodevelopmental Disorder - Benzinga
- 6 months ago - Shionogi & Co., Ltd. 2024 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 6 months ago - Shionogi targets JPY550B revenue through QOL focus and global expansion - Seeking Alpha
- 6 months ago - Shionogi & Co., Ltd. (SGIOY) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Shionogi & Co. reports 9M results - Seeking Alpha
- 9 months ago - Shionogi & Co., Ltd. (SGIOY) Q2 2024 Earnings Call Transcript - Seeking Alpha